Description
Artemether Injection 80mg / 40mg
Healthy Life Pharma / Healthy Inc is a specialized global supplier and exporter of sterile antimalarial injectables. We provide high-quality Artemether Injection, manufactured in our WHO–GMP certified sterile facilities. This rapid-acting antimalarial is a critical life-saving drug exported to hospitals, government tenders, and NGOs in Sub-Saharan Africa and Southeast Asia for the treatment of severe and complicated malaria.
Product Overview
This formulation contains Artemether, a lipid-soluble derivative of Artemisinin, dissolved in a specialized oil base for deep Intramuscular (IM) use.
The “Severe Malaria” Specialist:
- Rapid Onset: Acts quickly to reduce the parasite biomass in severe cases where oral medication is not possible.
- Cerebral Malaria: Highly effective in preventing mortality associated with cerebral malaria.
- Oily Formulation: Formulated in high-grade arachis oil or ethyl oleate to ensure slow, sustained release after injection.
- Sterility: Manufactured using aseptic filtration and terminal sterilization processes to ensure zero contamination.
Product Composition & Strength
We supply this product in amber glass ampoules to protect the light-sensitive active ingredient.
| Active Ingredient | Strength | Role |
|---|---|---|
| Artemether | 80 mg / 1 mL | Potent Antimalarial (Schizonticide) |
| Artemether | 40 mg / 1 mL | Pediatric Strength |
| Oily Vehicle | Q.S. | Solvent & Release Control |
*Available in Tray Packs or Blister Packs of 5, 6, or 10 Ampoules.
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers and Distributors.
| HS Code | 3004.90.99 (Antimalarial Injection) |
| Dosage Form | Sterile Liquid Injection (Oily) |
| Packaging | 1 mL Amber Glass Ampoule (Type I Glass) |
| Storage | Store below 25°C. Protect from light. Do not freeze. |
| Certificates | WHO-GMP, COPP, FSC, CTD Dossier |
Manufacturing Authority
Manufactured at our WHO-GMP & ISO 9001:2015 certified sterile injectable unit.
- Sterile Assurance: Produced in Class A (ISO 5) filling zones to guarantee sterility.
- Particle Count: Rigorous testing for sub-visible particles to prevent injection site reactions.
- Viscosity Control: Optimized viscosity to ensure smooth injectability through standard gauge needles.
Therapeutic Indications
Indicated for the treatment of:
- Severe Malaria: Including cerebral malaria caused by Plasmodium falciparum.
- Emergency Treatment: First-line treatment in patients who cannot tolerate oral medication due to vomiting or coma.
- Multi-Drug Resistance: Effective in areas with known chloroquine resistance.
Dosage & Administration
Recommended Dosage (Strictly as per Physician/Hospital Protocol):
- Route: Deep Intramuscular (IM) injection only.
- Loading Dose: 3.2 mg/kg body weight on the first day.
- Maintenance: 1.6 mg/kg body weight daily for subsequent days (typically up to 5-7 days) until the patient can take oral medication.
Safety Warnings:
- Administration: Do not inject intravenously (IV). It is an oily solution.
- Pregnancy: Use with caution during the first trimester, only if the benefit justifies the potential risk (severe malaria is often fatal).
Commercial Inquiries
For hospital tenders, bulk export, or distributor pricing, please contact our export team.
WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in
